| macromolecule catabolic process | GO:0009057 | 281 | 0.238 | |
| response to oxidative stress | GO:0006979 | 123 | 0.186 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.178 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.152 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.151 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.149 | |
| chromatin organization | GO:0006325 | 206 | 0.144 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.142 | |
| regulation of microvillus assembly | GO:0032534 | 3 | 0.136 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.134 | |
| gtp metabolic process | GO:0046039 | 144 | 0.113 | |
| muscle tissue development | GO:0060537 | 308 | 0.109 | |
| respiratory system development | GO:0060541 | 190 | 0.107 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.107 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.104 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.103 | |
| amine metabolic process | GO:0009308 | 45 | 0.101 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.100 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.100 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.098 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.095 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.094 | |
| multicellular organism growth | GO:0035264 | 161 | 0.092 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.091 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.088 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.086 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.085 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.085 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.084 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.084 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.083 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.082 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.082 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.079 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.079 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.078 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.077 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.076 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.074 | |
| muscle adaptation | GO:0043500 | 39 | 0.073 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.072 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.070 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.069 | |
| regulation of microvillus organization | GO:0032530 | 3 | 0.068 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.067 | |
| spermatogenesis | GO:0007283 | 284 | 0.067 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.065 | |
| ossification | GO:0001503 | 216 | 0.065 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.064 | |
| fat cell differentiation | GO:0045444 | 160 | 0.063 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.063 | |
| lung cell differentiation | GO:0060479 | 30 | 0.062 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.061 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.060 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.060 | |
| respiratory tube development | GO:0030323 | 167 | 0.059 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.059 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.058 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.058 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.056 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.056 | |
| regionalization | GO:0003002 | 337 | 0.054 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.054 | |
| stem cell development | GO:0048864 | 219 | 0.053 | |
| male gamete generation | GO:0048232 | 285 | 0.052 | |
| lung development | GO:0030324 | 164 | 0.052 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.051 | |
| chromatin modification | GO:0016568 | 187 | 0.050 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.049 | |
| primary neural tube formation | GO:0014020 | 95 | 0.049 | |
| protein catabolic process | GO:0030163 | 221 | 0.049 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.049 | |
| cardiac muscle hypertrophy in response to stress | GO:0014898 | 10 | 0.049 | |
| germ cell development | GO:0007281 | 185 | 0.049 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.049 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.049 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.048 | |
| neuron death | GO:0070997 | 154 | 0.048 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.047 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.047 | |
| rna processing | GO:0006396 | 105 | 0.047 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.047 | |
| lung epithelial cell differentiation | GO:0060487 | 29 | 0.046 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.046 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.046 | |
| gtp catabolic process | GO:0006184 | 143 | 0.046 | |
| forebrain development | GO:0030900 | 302 | 0.045 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.045 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.044 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.044 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.044 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.043 | |
| positive regulation of nuclear transcribed mrna poly a tail shortening | GO:0060213 | 4 | 0.043 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.043 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.042 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.041 | |
| oxidation reduction process | GO:0055114 | 342 | 0.041 | |
| epithelial cell development | GO:0002064 | 159 | 0.040 | |
| gland development | GO:0048732 | 330 | 0.039 | |
| blastocyst development | GO:0001824 | 80 | 0.039 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.039 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.038 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.038 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.038 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.037 | |
| hexose metabolic process | GO:0019318 | 98 | 0.037 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.037 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.037 | |
| mrna processing | GO:0006397 | 63 | 0.037 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.037 | |
| camera type eye development | GO:0043010 | 266 | 0.037 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.036 | |
| type i pneumocyte differentiation | GO:0060509 | 7 | 0.036 | |
| digestive system development | GO:0055123 | 200 | 0.036 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.036 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.036 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.036 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.035 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.035 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.035 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.035 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.035 | |
| organelle fission | GO:0048285 | 170 | 0.035 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.035 | |
| myotube differentiation | GO:0014902 | 105 | 0.035 | |
| apical constriction | GO:0003383 | 4 | 0.035 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.034 | |
| regulation of system process | GO:0044057 | 200 | 0.034 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.034 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.034 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.033 | |
| glial cell differentiation | GO:0010001 | 131 | 0.033 | |
| methylation | GO:0032259 | 134 | 0.033 | |
| striated muscle hypertrophy | GO:0014897 | 24 | 0.033 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.032 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.032 | |
| dendrite development | GO:0016358 | 115 | 0.032 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.032 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.032 | |
| blood circulation | GO:0008015 | 195 | 0.031 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.031 | |
| rna 3 end processing | GO:0031123 | 20 | 0.031 | |
| microtubule based process | GO:0007017 | 236 | 0.031 | |
| stem cell maintenance | GO:0019827 | 130 | 0.031 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.031 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.031 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.031 | |
| epidermis development | GO:0008544 | 187 | 0.031 | |
| macromolecule methylation | GO:0043414 | 120 | 0.031 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.031 | |
| regulation of cell motility | GO:2000145 | 236 | 0.031 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.031 | |
| response to inorganic substance | GO:0010035 | 96 | 0.031 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.030 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.030 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.030 | |
| stem cell differentiation | GO:0048863 | 268 | 0.030 | |
| muscle cell development | GO:0055001 | 133 | 0.030 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.030 | |
| response to acid chemical | GO:0001101 | 111 | 0.030 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.030 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.030 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.030 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.030 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.029 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.029 | |
| developmental maturation | GO:0021700 | 193 | 0.029 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.029 | |
| muscle system process | GO:0003012 | 141 | 0.029 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.029 | |
| glucose transport | GO:0015758 | 56 | 0.029 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.029 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.029 | |
| regulation of cell migration | GO:0030334 | 219 | 0.029 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.028 | |
| lung epithelium development | GO:0060428 | 37 | 0.028 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.028 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.028 | |
| nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:0000288 | 12 | 0.028 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.028 | |
| mrna metabolic process | GO:0016071 | 84 | 0.028 | |
| endocytosis | GO:0006897 | 168 | 0.028 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.028 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.027 | |
| striated muscle adaptation | GO:0014888 | 26 | 0.027 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.027 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.027 | |
| connective tissue development | GO:0061448 | 179 | 0.027 | |
| cell division | GO:0051301 | 120 | 0.026 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.026 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.026 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.026 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.026 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.026 | |
| angiogenesis | GO:0001525 | 201 | 0.026 | |
| skeletal system development | GO:0001501 | 356 | 0.026 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.026 | |
| neural tube closure | GO:0001843 | 90 | 0.026 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.025 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.025 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.025 | |
| oocyte construction | GO:0007308 | 2 | 0.025 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.024 | |
| protein maturation | GO:0051604 | 176 | 0.024 | |
| rna catabolic process | GO:0006401 | 29 | 0.024 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.024 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.024 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.024 | |
| bone development | GO:0060348 | 120 | 0.024 | |
| clara cell differentiation | GO:0060486 | 4 | 0.024 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.024 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.024 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.024 | |
| maintenance of location | GO:0051235 | 89 | 0.024 | |
| skin development | GO:0043588 | 220 | 0.023 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.023 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.023 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.023 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.023 | |
| glucose metabolic process | GO:0006006 | 92 | 0.023 | |
| cognition | GO:0050890 | 149 | 0.023 | |
| carbohydrate transport | GO:0008643 | 62 | 0.023 | |
| monosaccharide transport | GO:0015749 | 58 | 0.023 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.022 | |
| organelle localization | GO:0051640 | 179 | 0.022 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.022 | |
| muscle hypertrophy | GO:0014896 | 24 | 0.022 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.022 | |
| response to light stimulus | GO:0009416 | 135 | 0.022 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.022 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.022 | |
| regulation of ossification | GO:0030278 | 112 | 0.022 | |
| membrane organization | GO:0061024 | 245 | 0.022 | |
| protein oligomerization | GO:0051259 | 67 | 0.022 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.022 | |
| germ line stem cell division | GO:0042078 | 2 | 0.022 | |
| regulation of secretion | GO:0051046 | 274 | 0.022 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.022 | |
| learning or memory | GO:0007611 | 148 | 0.021 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.021 | |
| response to radiation | GO:0009314 | 165 | 0.021 | |
| neural tube development | GO:0021915 | 160 | 0.021 | |
| learning | GO:0007612 | 98 | 0.021 | |
| epithelial cell differentiation involved in kidney development | GO:0035850 | 23 | 0.021 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.021 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.021 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.021 | |
| intracellular protein transport | GO:0006886 | 204 | 0.021 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.021 | |
| protein processing | GO:0016485 | 163 | 0.021 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.021 | |
| gliogenesis | GO:0042063 | 141 | 0.021 | |
| viral gene expression | GO:0019080 | 3 | 0.021 | |
| neural tube formation | GO:0001841 | 108 | 0.021 | |
| embryonic placenta development | GO:0001892 | 98 | 0.021 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.021 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.021 | |
| neuronal action potential | GO:0019228 | 54 | 0.021 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.021 | |
| columnar cuboidal epithelial cell development | GO:0002066 | 29 | 0.020 | |
| action potential | GO:0001508 | 78 | 0.020 | |
| rhythmic process | GO:0048511 | 174 | 0.020 | |
| myosin filament assembly | GO:0031034 | 2 | 0.020 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.020 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.020 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.020 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.020 | |
| midgut development | GO:0007494 | 4 | 0.020 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.020 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.020 | |
| gene silencing | GO:0016458 | 38 | 0.020 | |
| cell maturation | GO:0048469 | 127 | 0.020 | |
| response to peptide | GO:1901652 | 136 | 0.020 | |
| nuclear transport | GO:0051169 | 139 | 0.019 | |
| rna interference | GO:0016246 | 2 | 0.019 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.019 | |
| organ growth | GO:0035265 | 117 | 0.019 | |
| tube closure | GO:0060606 | 91 | 0.019 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.019 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.019 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.019 | |
| epithelial tube formation | GO:0072175 | 130 | 0.019 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.019 | |
| positive regulation of fat cell differentiation | GO:0045600 | 32 | 0.019 | |
| male germ line stem cell asymmetric division | GO:0048133 | 2 | 0.019 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.019 | |
| transmembrane transport | GO:0055085 | 412 | 0.019 | |
| positive regulation of mrna 3 end processing | GO:0031442 | 5 | 0.019 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.019 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.019 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.019 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.019 | |
| liver development | GO:0001889 | 66 | 0.019 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.019 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.019 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.018 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.018 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.018 | |
| myosin filament organization | GO:0031033 | 3 | 0.018 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.018 | |
| cardiac muscle hypertrophy | GO:0003300 | 23 | 0.018 | |
| lateral inhibition | GO:0046331 | 1 | 0.018 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.018 | |
| kidney development | GO:0001822 | 213 | 0.018 | |
| protein ubiquitination | GO:0016567 | 171 | 0.018 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 38 | 0.018 | |
| actin filament organization | GO:0007015 | 113 | 0.018 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.018 | |
| regulation of nuclear transcribed mrna poly a tail shortening | GO:0060211 | 4 | 0.018 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.018 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.018 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.018 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.018 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.018 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.018 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.018 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.018 | |
| nuclear transcribed mrna poly a tail shortening | GO:0000289 | 7 | 0.018 | |
| female gamete generation | GO:0007292 | 74 | 0.018 | |
| response to nutrient levels | GO:0031667 | 109 | 0.017 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.017 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.017 | |
| regulation of mrna 3 end processing | GO:0031440 | 6 | 0.017 | |
| hexose transport | GO:0008645 | 56 | 0.017 | |
| response to peptide hormone | GO:0043434 | 127 | 0.017 | |
| glomerulus development | GO:0032835 | 40 | 0.017 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.017 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.017 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.017 | |
| b cell activation | GO:0042113 | 161 | 0.017 | |
| mitochondrion organization | GO:0007005 | 134 | 0.017 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.017 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.017 | |
| telencephalon development | GO:0021537 | 186 | 0.017 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.017 | |
| organelle assembly | GO:0070925 | 177 | 0.017 | |
| cellular response to peptide | GO:1901653 | 92 | 0.017 | |
| adaptive immune response | GO:0002250 | 155 | 0.017 | |
| mapk cascade | GO:0000165 | 281 | 0.016 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.016 | |
| protein localization to organelle | GO:0033365 | 185 | 0.016 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.016 | |
| cell adhesion | GO:0007155 | 329 | 0.016 | |
| protein homotrimerization | GO:0070207 | 4 | 0.016 | |
| sensory perception of umami taste | GO:0050917 | 4 | 0.016 | |
| cellular homeostasis | GO:0019725 | 240 | 0.016 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.016 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.016 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.016 | |
| cation transport | GO:0006812 | 399 | 0.016 | |
| nuclear division | GO:0000280 | 158 | 0.016 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.016 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.016 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.016 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.016 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.016 | |
| heart contraction | GO:0060047 | 93 | 0.016 | |
| blastocyst formation | GO:0001825 | 33 | 0.016 | |
| mitotic cytokinesis | GO:0000281 | 4 | 0.016 | |
| placenta development | GO:0001890 | 140 | 0.016 | |
| immune effector process | GO:0002252 | 321 | 0.016 | |
| associative learning | GO:0008306 | 61 | 0.016 | |
| body morphogenesis | GO:0010171 | 45 | 0.016 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.015 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.015 | |
| negative regulation of bmp signaling pathway | GO:0030514 | 35 | 0.015 | |
| nephron development | GO:0072006 | 109 | 0.015 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.015 | |
| cleavage furrow formation | GO:0036089 | 2 | 0.015 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.015 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.015 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.015 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.015 | |
| axonogenesis | GO:0007409 | 274 | 0.015 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.015 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.015 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.015 | |
| positive regulation of protein export from nucleus | GO:0046827 | 4 | 0.015 | |
| fibroblast proliferation | GO:0048144 | 35 | 0.015 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.015 | |
| renal system development | GO:0072001 | 225 | 0.015 | |
| regulation of cell projection assembly | GO:0060491 | 38 | 0.015 | |
| mrna 3 end processing | GO:0031124 | 16 | 0.015 | |
| cartilage development | GO:0051216 | 140 | 0.015 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.015 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.015 | |
| circulatory system process | GO:0003013 | 197 | 0.015 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.015 | |
| olfactory learning | GO:0008355 | 2 | 0.015 | |
| mrna catabolic process | GO:0006402 | 22 | 0.015 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.015 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.014 | |
| smad protein signal transduction | GO:0060395 | 21 | 0.014 | |
| kidney epithelium development | GO:0072073 | 121 | 0.014 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.014 | |
| regulation of fibroblast proliferation | GO:0048145 | 34 | 0.014 | |
| regulation of protein processing | GO:0070613 | 96 | 0.014 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.014 | |
| skin morphogenesis | GO:0043589 | 38 | 0.014 | |
| cerebral cortex development | GO:0021987 | 86 | 0.014 | |
| cytokine production | GO:0001816 | 319 | 0.014 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.014 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.014 | |
| limb development | GO:0060173 | 166 | 0.014 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.014 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.014 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.014 | |
| cation homeostasis | GO:0055080 | 212 | 0.014 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.014 | |
| oocyte axis specification | GO:0007309 | 2 | 0.014 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.014 | |
| cellular response to lipid | GO:0071396 | 145 | 0.014 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.014 | |
| erythrocyte maturation | GO:0043249 | 6 | 0.014 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.014 | |
| protein deacetylation | GO:0006476 | 32 | 0.014 | |
| regulation of neuron death | GO:1901214 | 134 | 0.014 | |
| osteoclast differentiation | GO:0030316 | 62 | 0.013 | |
| regulation of protein acetylation | GO:1901983 | 22 | 0.013 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.013 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.013 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.013 | |
| spermatid differentiation | GO:0048515 | 115 | 0.013 | |
| striated muscle cell development | GO:0055002 | 125 | 0.013 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.013 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.013 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.013 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.013 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.013 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.013 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.013 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.013 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.013 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.013 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.013 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.013 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.013 | |
| fertilization | GO:0009566 | 127 | 0.013 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.013 | |
| dna metabolic process | GO:0006259 | 303 | 0.013 | |
| single organism nuclear import | GO:1902593 | 95 | 0.013 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.013 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.013 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.013 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.013 | |
| response to retinoic acid | GO:0032526 | 56 | 0.013 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.013 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.013 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.013 | |
| regulation of binding | GO:0051098 | 111 | 0.013 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.013 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.013 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.013 | |
| limb morphogenesis | GO:0035108 | 149 | 0.012 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.012 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.012 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.012 | |
| intestinal epithelial cell development | GO:0060576 | 12 | 0.012 | |
| response to purine containing compound | GO:0014074 | 28 | 0.012 | |
| regulation of protein deacetylation | GO:0090311 | 17 | 0.012 | |
| polysaccharide metabolic process | GO:0005976 | 39 | 0.012 | |
| regulation of protein localization | GO:0032880 | 231 | 0.012 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.012 | |
| sensory system development | GO:0048880 | 3 | 0.012 | |
| protein deacylation | GO:0035601 | 36 | 0.012 | |
| natural killer cell proliferation | GO:0001787 | 3 | 0.012 | |
| negative regulation of translation | GO:0017148 | 22 | 0.012 | |
| muscle fiber development | GO:0048747 | 76 | 0.012 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.012 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.012 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.012 | |
| cell growth | GO:0016049 | 130 | 0.012 | |
| regulation of cell division | GO:0051302 | 76 | 0.012 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.012 | |
| protein import | GO:0017038 | 101 | 0.012 | |
| natural killer cell activation | GO:0030101 | 44 | 0.012 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.012 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.012 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.012 | |
| response to oxygen levels | GO:0070482 | 62 | 0.012 | |
| nephron epithelium development | GO:0072009 | 92 | 0.012 | |
| heart morphogenesis | GO:0003007 | 178 | 0.012 | |
| regulation of osteoclast differentiation | GO:0045670 | 36 | 0.012 | |
| sensory perception | GO:0007600 | 245 | 0.012 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.012 | |
